The influence of transcranial alternating current stimulation (tACS) on fluid intelligence: An fMRI study

por Neubauer, A.C., Wammerl, M., Benedek, M., Jauk, E., Jaušovec, N.
Publicado 2017

Molecular alterations in a patient with Turcot's syndrome.

por Rochlitz, C. F., Heide, I., de Kant, E., Neubauer, A., Schmidt, C. A., Neuhaus, P., Huhn, D., Herrmann, R.
Publicado 1993

Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients

por Jäger, R, List, B, Knabbe, C, Souttou, B, Raulais, D, Zeiler, T, Wellstein, A, Aigner, A, Neubauer, A, Zugmaier, G
Publicado 2002

Heat‐labile Escherichia coli toxin enhances the induction of allergen‐specific IgG antibodies in epicutaneous patch vaccination

por Cabauatan, C. R., Campana, R., Niespodziana, K., Reinisch, C., Lundberg, U., Meinke, A., Henning, R., Neubauer, A., Valenta, R.
Publicado 2016

CD11c(+) dendritic cells mediate antigen‐specific suppression in extracorporeal photopheresis

por Hackstein, H., Kalina, A., Dorn, B., Keil, I. S., Baal, N., Michel, G., Brendel, C., Neubauer, A., Jakob, T., Bein, G.
Publicado 2020

Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer

por Maurer, Elisabeth, Eilsberger, F., Wächter, S., Riera Knorrenschild, J., Pehl, A., Holzer, K., Neubauer, A., Luster, M., Bartsch, D. K.
Publicado 2023

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymp...

por Schmidt-Wolf, I G H, Finke, S, Trojaneck, B, Denkena, A, Lefterova, P, Schwella, N, Heuft, H-G, Prange, G, Korte, M, Takeya, M, Dorbic, T, Neubauer, A, Wittig, B, Huhn, D
Publicado 1999

Amb a 1 isoforms: Unequal siblings with distinct immunological features

por Wolf, M., Twaroch, T. E., Huber, S., Reithofer, M., Steiner, M., Aglas, L., Hauser, M., Aloisi, I., Asam, C., Hofer, H., Parigiani, M. A., Ebner, C., Bohle, B., Briza, P., Neubauer, A., Stolz, F., Jahn‐Schmid, B., Wallner, M., Ferreira, F.
Publicado 2017

Karyotype complexity and prognosis in acute myeloid leukemia

por Stölzel, F, Mohr, B, Kramer, M, Oelschlägel, U, Bochtler, T, Berdel, W E, Kaufmann, M, Baldus, C D, Schäfer-Eckart, K, Stuhlmann, R, Einsele, H, Krause, S W, Serve, H, Hänel, M, Herbst, R, Neubauer, A, Sohlbach, K, Mayer, J, Middeke, J M, Platzbecker, U, Schaich, M, Krämer, A, Röllig, C, Schetelig, J, Bornhäuser, M, Ehninger, G
Publicado 2016

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

por Hehlmann, R, Lauseker, M, Saußele, S, Pfirrmann, M, Krause, S, Kolb, H J, Neubauer, A, Hossfeld, D K, Nerl, C, Gratwohl, A, Baerlocher, G M, Heim, D, Brümmendorf, T H, Fabarius, A, Haferlach, C, Schlegelberger, B, Müller, M C, Jeromin, S, Proetel, U, Kohlbrenner, K, Voskanyan, A, Rinaldetti, S, Seifarth, W, Spieß, B, Balleisen, L, Goebeler, M C, Hänel, M, Ho, A, Dengler, J, Falge, C, Kanz, L, Kremers, S, Burchert, A, Kneba, M, Stegelmann, F, Köhne, C A, Lindemann, H W, Waller, C F, Pfreundschuh, M, Spiekermann, K, Berdel, W E, Müller, L, Edinger, M, Mayer, J, Beelen, D W, Bentz, M, Link, H, Hertenstein, B, Fuchs, R, Wernli, M, Schlegel, F, Schlag, R, de Wit, M, Trümper, L, Hebart, H, Hahn, M, Thomalla, J, Scheid, C, Schafhausen, P, Verbeek, W, Eckart, M J, Gassmann, W, Pezzutto, A, Schenk, M, Brossart, P, Geer, T, Bildat, S, Schäfer, E, Hochhaus, A, Hasford, J
Publicado 2017